Starpharma Holdings Ltd SPHRF:OTCQX

RT Quote | Exchange | USD
Last | 04/16/21 EDT
1.52UNCH (UNCH)
52 week range
0.56 - 1.79

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.52
  • 52 Week High1.79
  • 52 Week High Date02/23/21
  • 52 Week Low0.56
  • 52 Week Low Date05/11/20

Key Stats

  • Market Cap600.9M
  • Shares Out40.6M
  • 10 Day Average Volume2,002.25
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change23.58

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.52
  • 52 Week High1.79
  • 52 Week High Date02/23/21
  • 52 Week Low0.56
  • 52 Week Low Date05/11/20
  • Market Cap600.9M
  • Shares Out40.6M
  • 10 Day Average Volume2,002.25
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change23.58

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-39.07
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Starpharma Holdings Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Starpharma Holdings Limited is engaged in development of dendrimer products for pharmaceutical, life science and other applications. The Company utilizes dendrimers, which is a type of synthetic nanoscale polymer that is regular in size and structure and suited to pharmaceutical and medical uses. The Company’s development programs, including VivaGel portfolio and DEP drug delivery. The Company’s DEP drug delivery, which includes DEP docetaxel, DEP cabazitaxel, DEP irinotecan...
Robert Thomas
Non-Executive Chairman
Jacinth Fairley
Chief Executive Officer
Nigel Baade CPA
Chief Financial Officer
David Owen Ph.D.
Vice President
Jeremy Paull Ph.D.
Vice President
Address
4-6 Southampton Crescent, Abbotsford
Melbourne, VIC
3067
Australia